StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The downward revision in forecast indicates limited growth potential and existing financial weaknesses. Historical data shows similar analyst downgrades often preceded further stock declines.
What happened, with direct paths to the underlying reporting
J.P. Morgan maintains Underweight rating on FUL, lowering forecast to $50. First-quarter revenue fell 2.7% to $789 million, organic growth up 1.9%. Health segment saw EBITDA drop 25%, signaling ongoing weakness. Adjusted EBITDA expected to grow only 1% in FY2025 amidst market softness. Solar panel business may decline 20% due to oversupply in China.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.